Kv1.3 blocking alkoxypsoralens - A new class of immunosuppressants for the potential treatment of multiple sclerosis

被引：0
|
作者：
Wulff, H
Vennekamp, J
Beeton, C
Grissmer, S
Chandy, KG
机构：
[1] Univ Calif Irvine, Irvine, CA 92697 USA
[2] Univ Ulm, D-89069 Ulm, Germany
[3] Univ Kiel, Inst Pharmaceut, D-24098 Kiel, Germany
来源：
FASEB JOURNAL | 2003年 / 17卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A1051 / A1051
页数：1
相关论文
共 50 条
  • [21] Synthesis and Folding of Kv1.3 Ion-Channel Blocking Peptides
    Dello Iacono, G. D. I.
    Desharnais, J.
    Leedom, T.
    Bhat, A.
    Tumelty, D.
    Wood, L.
    Levin, N.
    Woodnutt, G.
    JOURNAL OF PEPTIDE SCIENCE, 2010, 16 : 59 - 59
  • [22] Design and characterization of a novel structural class of Kv1.3 inhibitors
    Hendrickx, Louise Antonia
    Dobricic, Vladimir
    Toplak, Zan
    Peigneur, Steve
    Masic, Lucija Peterlin
    Tomasic, Tihomir
    Tytgat, Jan
    BIOORGANIC CHEMISTRY, 2020, 98
  • [23] Novel Kv1.3 blockers for the treatment of autoimmune diseases
    Kudryashova, K.
    Kuzmenkov, A.
    Nekrasova, O.
    Feofanov, A.
    Grishin, E.
    Vassilevski, A.
    FEBS JOURNAL, 2014, 281 : 149 - 149
  • [24] Kv1.3: A promising target for the treatment of autoimmune diseases
    Tasler, Stefan
    Pruetting, Sylvia
    Hamm, Svetlana
    Dreker, Tobias
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [25] Kv1.3-blocking 5-phenylalkoxypsoralens:: A new class of immunomodulators
    Vennekamp, J
    Wulff, H
    Beeton, C
    Calabresi, PA
    Grissmer, S
    Hänsel, W
    Chandy, KG
    MOLECULAR PHARMACOLOGY, 2004, 65 (06) : 1364 - 1374
  • [26] Kv1.3 channels in chronically activated autoreactive T cells: Novel therapeutic target for multiple sclerosis
    Beeton, C
    Wulff, H
    Pennington, M
    Clot-Faybesse, O
    Barbaria, J
    Cahalan, M
    Chandy, KG
    Beraud, E
    BIOPHYSICAL JOURNAL, 2002, 82 (01) : 195A - 195A
  • [27] Increased expression of Kv1.3 channels in peripheral blood T-lymphocytes of patients with multiple sclerosis
    Poulopoulou, C.
    Rombos, A.
    Hadjimanolis, A.
    Markakis, I.
    Vassilopoulos, D.
    Davaki, P.
    JOURNAL OF NEUROLOGY, 2009, 256 : S87 - S88
  • [28] Rational design of a Kv1.3 channel-blocking antibody as a selective immunosuppressant
    Wang, Rongsheng E.
    Wang, Ying
    Zhang, Yuhan
    Gabrelow, Chase
    Zhang, Yong
    Chi, Victor
    Fu, Qiangwei
    Luo, Xiaozhou
    Wang, Danling
    Joseph, Sean
    Johnson, Kristen
    Chatterjee, Arnab K.
    Wright, Timothy M.
    Nguyen-Tran, Van T. B.
    Teijaro, John
    Theofilopoulos, Argyrios N.
    Schultz, Peter G.
    Wang, Feng
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (41) : 11501 - 11506
  • [29] Kv1.3 Channel Up-Regulation in Peripheral Blood T Lymphocytes of Patients With Multiple Sclerosis
    Markakis, Ioannis
    Charitakis, Ioannis
    Beeton, Christine
    Galani, Melpomeni
    Repousi, Elpida
    Aggeloglou, Stella
    Sfikakis, Petros P.
    Pennington, Michael W.
    Chandy, K. George
    Poulopoulou, Cornelia
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [30] TREATMENT OF MULTIPLE-SCLEROSIS WITH IMMUNOSUPPRESSANTS
    FINKE, J
    MEDIZINISCHE WELT, 1979, 30 (47): : 1794 - 1794
12345